Warning letter
IIT Research Institute: warning letter of Dec 5, 2005
FDA warning letter UCM075728 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM075728 |
|---|---|
| Company | IIT Research Institute |
| Subject | GLP for non-clincal laboratory studies |
| Issue date | Dec 5, 2005 |
| Posted date | Dec 5, 2005 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 58, 58.3(o), 58.31(d), 58.120(a), 58.120(a)(11), 58.130(a), 58.130(e), 58.185(a)(4), 58.185(a)(9) |
| Country | 3 |
| Inspection city | Chicago |
| Inspection ZIP | 60616-3717 |
| Inspection start date | Jan 3, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: